Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...

Stifel analysts adjusted their outlook on Caesars Entertainment (NASDAQ:CZR), lowering the price target to $51.00 from the previous $54.00 while still maintaining a Buy rating on the stock. Currently ...

Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...

In a report released today, Daryl Young from Stifel Nicolaus maintained a Buy rating on Air Canada (ACDVF – Research Report), with a price ...

Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

HB Wealth Management LLC raised its stake in shares of The Hershey Company (NYSE:HSY – Free Report) by 20.7% during the ...

The news comes a few months after VF announced the closure of its East Coast distribution center (DC), the closure of the ...

Voyager's IPO highlights Palantir's expanding AI footprint in defense and space, as analysts weigh PLTR's long-term upside ...